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Abstract
CXXC finger protein 1 (Cfp1), encoded by the Cxxc1 gene, binds to DNA
sequences containing an unmethylated CpG dinucleotide and is an epigenetic
regulator of both cytosine and histone methylation. Cxxc1-null mouse embryos fail
to gastrulate, and Cxxc1-null embryonic stem cells are viable but cannot
differentiate, suggesting that Cfp1 is required for chromatin remodeling associated
with stem cell differentiation and embryogenesis. Mice homozygous for a
conditional Cxxc1 deletion allele and carrying the inducible Mx1-Cre transgene
were generated to assess Cfp1 function in adult animals. Induction of Cre
expression in adult animals led to Cfp1 depletion in hematopoietic cells, a failure of
hematopoiesis with a nearly complete loss of lineage-committed progenitors and
mature cells, elevated levels of apoptosis, and death within two weeks. A similar
pathology resulted following transplantation of conditional Cxxc1 bone marrow cells
into wild type recipients, demonstrating this phenotype is intrinsic to Cfp1 function
within bone marrow cells. Remarkably, the Lin2Sca-1+c-Kit+ population of cells in
the bone marrow, which is enriched for hematopoietic stem cells and multi-potential
progenitor cells, persists and expands in the absence of Cfp1 during this time
frame. Thus, Cfp1 is necessary for hematopoietic stem and multi-potential
progenitor cell function and for the developmental potential of differentiating
hematopoietic cells.
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Introduction
Hematopoiesis is a dynamic process in which multipotent hematopoietic stem
cells (HSCs) give rise to all lineages of mature blood cells. HSC differentiation is
balanced with self-renewal, which maintains a pool of stem cells that sustain
hematopoiesis for the lifespan of the organism [1, 2]. How this balance is
controlled at the molecular level remains unclear, but regulation of chromatin
structure clearly plays a critical role. Indeed, altered patterns of epigenetic
modifications have been linked to HSC aging [3], and epigenetic reprogramming
can reset aged HSCs into a young state [4]. Furthermore, stem cell lineage
commitment and cellular differentiation involve global remodeling of chromatin
structure and a progressive accumulation of heterochromatin and restriction of
gene expression and developmental potential [5, 6].
Mammalian CXXC finger protein 1 (Cfp1), encoded by the Cxxc1 gene, is an
important epigenetic regulator that interacts with DNA sequences containing an
unmethylated CpG dinucleotide [7, 8]. Cfp1-deficient embryonic stem (ES) cells
are viable but fail to differentiate in vitro [9]. These ES cells exhibit a 70% loss of
global genomic cytosine methylation and reduced maintenance DNA methy-
transferase (Dnmt) activity. Cfp1 physically interacts with Dnmt1 [10], and cells
lacking Cfp1 express reduced levels of Dnmt1 protein due to reduced Dnmt1 half-
life and translation efficiency [11]. Mouse embryos lacking Cfp1 exhibit a peri-
implantation death and fail to gastrulate [12]. Cfp1 is also a component of the
Setd1A and Setd1B histone H3-Lys4 methyltransferase complexes [13, 14].
Ablation of the murine gene encoding either Setd1A or Setd1B leads to embryonic
lethality, and Setd1A is also required for ES cell viability and for the derivation of
induced pluripotent stem cells [15].
Cxxc1-null ES cells contain elevated levels of histone H3-Lys4 methylation and
reduced levels of histone H3-Lys9 methylation [13]. This is consistent with the
observed reduction in genomic cytosine methylation, and suggests a reduction in
the level of heterochromatin in cells lacking Cfp1. Cfp1 appears necessary to
restrict the activity of the Setd1 histone methyltransferase complexes, as both
Setd1A protein and histone H3-Lys4 methylation inappropriately partially co-
localize with heterochromatin in the absence of Cfp1 [16]. Consistent with this
finding, chromatin immunoprecipitation studies found that Cfp1 is bound to
80% of unmethylated CpG islands in vivo, and depletion of Cfp1 leads to loss of
histone H3-Lys4 tri-methylation at these sites [17]. Thus, Cfp1 appears to serve as
a reader of cytosine methylation patterns and to tether the Setd1 histone H3-Lys4
methyltransferases to appropriate sites in the genome. The global increase in
histone H3-Lys4 methylation following depletion of Cfp1, despite its loss at CpG
islands, could therefore be explained by the failure of Cfp1 to restrict Setd1
localization to CpG islands, and the inappropriate drifting of methyltransferases
throughout the genome. Thus, Cfp1 is a critical regulator of both cytosine
methylation and histone methylation, and may function to integrate these
epigenetic modifications during development. Surprisingly, targeting of histone
H3-Lys4 tri-methylation to CpG islands is largely rescued upon introduction of a
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mutated form of Cfp1 that lacks DNA-binding activity [18], suggesting that the
mechanism of Cfp1 action is more complex than originally hypothesized.
Mouse embryos lacking Cfp1 exhibit a peri-implantation death and fail to
gastrulate [12], demonstrating that Cfp1 is essential for embryonic development.
Furthermore, injection of zebrafish embryos with antisense morpholino
oligonucleotides specific to the Cxxc1 transcript leads to embryo runting, cardiac
edema, and a failure of primitive hematopoiesis [19]. These gross zebrafish
developmental abnormalities are associated with a 60% decline in global genomic
cytosine methylation levels [19]. In addition, shRNA-mediated depletion of Cfp1
inhibits the survival and differentiation capacity of human myeloid cell lines [20].
Thus, Cfp1 is not only required for early developmental processes but is also
required for post-gastrulation vertebrate development. Given that Cfp1 is a
regulator of both cytosine methylation and histone methylation, it is intriguing
that the developmental timing of Cxxc1-null mouse embryo death coincides with
a time of global epigenetic remodeling, raising the possibility that Cfp1 plays a
role in regulating this wave of epigenetic reprogramming.
The early death of Cxxc1-null mouse embryos prevented an assessment of Cfp1
function during later mammalian development and adult homeostasis. To address
this question, mice were developed that are homozygous for a conditional Cxxc1
allele and carry the Mx1-Cre recombinase transgene which can be induced in a
wide range of tissues, particularly the liver and all hematopoietic cell lineages
[21, 22, 23, 24]. Ablation of the Cxxc1 gene in adult mice leads to a rapid loss of
bone marrow progenitors and mature peripheral blood cells, and death within
two weeks. Remarkably, the Lin2Sca-1+c-Kit+ (LSK) population of cells in the
bone marrow, which is enriched for HSCs and multipotential progenitor cells
(MPPs), persists and expands in the absence of Cfp1 during this time frame. In
addition, Cfp1-deficient LSK cells exhibit neither reduced apoptosis nor increased
proliferation. Overall, these findings indicate that Cfp1 is required for
hematopoietic cell differentiation and/or the survival of differentiating cells.
Materials and Methods
Generation of a conditional Cxxc1 allele
A conditional targeting vector based on the Cre-loxP system was constructed
using the murine Cxxc1 gene [25]. Linearized targeting vector was transfected into
ES cells, and positive (G418)-negative (gancylovir) selection was performed. DNA
from recovered ES clones was analyzed by Southern blot and PCR to identify
homologous recombination events. PCR primers utilized in these studies include:
LOXP1F, 59-tgtagacacttgtgggaagcc-39; LOXP1R, 59-tgggctctatggcttctgagg-39;
LOXP3F, 59-actgtttagccatctccc-39; LOXP3R, 59-gttcctgctcaaagagctcg-39; CXXC1F,
59-ttcgctgatcgttgcttccc-39; and CXXC1R, 59-agttcacccagaccctcttc-39. An ES clone
carrying the targeted Cxxc1 allele was used for blastocyst injections and generation
of chimeric animals. Mice heterozygous for the targeted Cxxc1 allele were bred
with mice carrying the EIIa-Cre transgene to remove the Neo cassette from intron
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1 [26]. A mouse heterozygous for the conditional Cxxc1 allele was backcrossed
with C57BL/6J mice, and offspring carrying the conditional Cxxc1 allele were bred
with transgenic animals carrying the Mx1-Cre recombinase transgene [22].
Ethics statement
This study was carried out in strict accordance with the recommendations in the
Guide for the Care and Use of Laboratory Animals of the National Institutes of
Health. The protocol was approved by the Institutional Animal Care and Use
Committee of the Indiana University School of Medicine (Study Number: 3256).
All efforts were made to minimize suffering.
In vivo induction of the Cre recombinase and ex vivo culturing of
primary bone marrow cells
Sex- and age-matched 6–12 week old mice were used for all experiments. To
induce expression of the Cre recombinase, polyinosine-polycytosine (poly(I:C))
(GE Healthcare, Piscataway, NJ) was administered as three intraperitoneal
injections (250 mg) at 2 day intervals [22, 27]. For ex vivo culturing, 16106 cells/
ml of low density bone marrow cells (LDBMCs) were plated on 3.5 cm non-tissue
culture dishes in IMDM medium supplemented with 20% FBS, 100 ng/ml
thrombopoietin (TPO), 100 ng/ml stem cell factor (SCF), 50 ng/ml Flt-3 ligand,
and 200 U/ml IL-6 (Peprotech, Rocky Hill, NJ) [27, 28].
Immunoblots
Whole-cell lysates were prepared using 10 mM PIPES pH 7.0 containing 300 mM
NaCl, 300 mM sucrose, 3 mM MgCl2, 1 mM EGTA, 0.5% Triton X-100, and
protease inhibitors. Protein concentrations were determined by the Bradford
protein assay, and immunoblots were performed as previously described [29].
Polyclonal anti-Cfp1 rabbit antiserum was used at a 1:2500 dilution as previously
described [14], and anti-actin monoclonal antibody was obtained from Sigma-
Aldrich (St. Louis, MO).
Histology
Tissues were collected in 10% neutral-buffered formalin. Bones were decalcified
for 3 days prior to embedding (Formic Decalcifying Solution; US Biotex,
Webbville, KY). Tissues were dehydrated, embedded, sectioned at 6 microns, and
stained with hematoxylin and eosin.
Hematopoietic cell analyses
Peripheral blood cell counts were determined from 50 microliter blood samples
using a Hemavet analyzer. Spleen and bone marrow cell suspensions were
prepared by flushing spleens or femurs with RPMI 1640 medium plus 10% FBS
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and 100 U/ml penicillin/streptomycin, and LDBMCs were prepared and
progenitor colony forming activity was assayed as previously described [27, 28].
Briefly, LDBMCs were prepared by centrifugation on ficoll-hypaque (density
1.119; Histopaque-1119; Sigma –Aldrich). Cells were suspended in triplicate into
10635 mm grid culture dishes with 1.2% methylcellulose (MethoCult M3134,
StemCell Technologies; Vancouver, BC, Canada), 30% FBS, 1% deionized fraction
V bovine serum albumin (Sigma-Aldrich), 0.1 mM bb-mercaptoethanol, and
cytokines (100 ng/ml recombinant murine IL-3 (Peprotech), 100 ng/ml recom-
binant human erythropoietin (Amgen; Thousand Oaks, CA), and 100 ng/ml
recombinant murine SCF (Peprotech)), followed by 7 days of incubation at 37 C˚,
5% CO2 in a humidified incubator. Colony types were determined by observation
using an inverted microscope and according to documented criteria [30].
For analysis of phenotypically defined hematopoietic cell populations, LDBMCs
were isolated from 6–12 week old mice and suspended in IMDM medium
supplemented with 10% FCS. To characterize LSK cells and subpopulations,
16106 cells were stained with an antibody cocktail composed of 0.125 microgram
each of biotinylated antibodies for lineage markers CD11b/Mac-1 (M1/70), CD4
(RM4-5), CD8 (53-6.7), CD45R/B220 (RA3-6B2), Gr-1 (RB6-8C5), and TER119
(eBioscience Inc.; San Diego, CA) in 100 microliters of phosphate buffered saline
(PBS) with 0.1% bovine serum albumin (BSA) on ice for 20 min. Samples were
washed with PBS and 0.1% BSA, and stained with 0.5 microgram streptiavidin-
Cy5.5 conjugated secondary antibody, 0.5 microgram PE-Cy7 conjugated anti-
Sca-1, 0.5 microgram of allophycocyanin (APC)-conjugated anti-c-Kit, anti-Flt3/
Flk2-PE, and anti-CD34-FITC antibodies (BD Pharmingen; San Diego, CA or
eBioscience) on ice for 20 min, washed, and analyzed with a Becton Dickinson
LSRII flow cytometer. To detect myeloid and lymphoid progenitors, LDBMCs
were stained with 0.125 microgram each of biotinylated antibodies for the same
lineage markers, and then stained with 0.5 microgram streptavidin-PE-Cy5.5
secondary antibody (eBioscience; San Diego, CA). Cells were stained with
combinations of 0.5 microgram each of the indicated antibodies: anti-CD127/
IL7Ra-APC-Alexa Fluor 750, anti-FcgRII/III-PE, anti-CD34-FITC, anti-Sca-1-PE-
Cy7, and anti-c-Kit-APC monoclonal antibodies (BD Pharmingen or eBioscience)
prior to flow cytometer analysis.
Bone marrow transplantation studies
Bone marrow cells were isolated from Cxxc1flox/floxMx1-Cre mutant mice or
Cxxc1flox/flox mice lacking the Mx1-Cre transgene control donors, and 36106
LDBMCs were transplanted by tail vein injection into 6–12 week old wild type
lethally irradiated recipients (1,100 cGy split dose) [31].
Flow cytometric analysis of apoptosis and proliferation
Apoptosis assays were performed as previously described [28]. Briefly, freshly
isolated LDBMCs or 16105 cells cultured ex vivo were harvested, washed once
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with PBS, and resuspended in 100 microliters of binding buffer (10 mM HEPES/
NaOH pH 7.4, 140 mM NaCl, and 2.5 mM CaCl2). Cells were then stained with 5
microliters of AnnexinV-FITC (BD Pharmingen) and 500 ng of propidium iodide
(PI) for in vitro cultured cells. When freshly isolated LDBMCs were analyzed,
these cells were incubated with 5 microliters AnnexinV-FITC and 5 microliters
(0.25 microgram) 7-AAD. Stained cells were incubated at room temperature for
15 min in the dark, and binding buffer (400 microliters) was then added prior to
flow cytometric analysis using a FACScan flow cytometer. Apoptotic cells were
defined as the fraction of Annexin V positive, and PI or 7-AAD negative cells.
To measure proliferation in vivo, poly(I:C) was administered as described
above. Seven days after the first injection, 200 microliters of 10 mg/ml
bromodeoxyuridine (BrdU) was administered by intraperitoneal injection.
Twenty four hours later, LDBMCs were isolated and 16106 cells were stained
with the antibodies listed above for lineage markers, and by 0.5 microgram
streptavidin-APC-Cy7 secondary antibody, anti-Sca-1-PE-Cy7, anti-c-Kit-APC,
anti-CD34-Pacific Blue, and anti-Flt3/Flk2-PE (BD Pharmingen and
eBiosciences). Cells were then fixed, permabilized, and BrdU was detected in LSK
cells and subpopulations using a FITC BrdU Flow Kit (BD Pharmingen) and a
Becton Dickinson LSRII flow cytometer.
Analysis of global genomic cytosine methylation levels
Genomic DNA was isolated from the indicated cell populations and the relative
level of genomic cytosine methylation was assessed using a methyl-acceptance
assay, as previously described [9].
Results
Generation of mice carrying a conditional Cxxc1 allele
Cfp1 is widely expressed [25], but the peri-implantation death of Cfp1-null mouse
embryos prevented analysis of Cfp1 function later in mammalian development
[12]. To determine the requirement of Cfp1 for homeostasis in an adult mammal,
a mouse strain carrying a Cxxc1 conditional deletion allele was generated
(Figure 1A–E). An ES clone carrying the targeted Cxxc1 allele was used for
blastocyst injections and generation of chimeric animals, which were backcrossed
with C57Bl/6J mice. Mice heterozygous for the targeted Cxxc1 allele were bred
with mice carrying the EIIa-Cre transgene in order to remove the NeoR cassette
from intron 1 (Figure 1F) [26]. Mice carrying the conditional Cxxc1 allele were
bred with transgenic animals carrying the Mx1-Cre transgene (Figure 1G) to
permit the poly(I:C)-inducible expression of Cre in a wide variety of tissues,
including bone marrow cells [22, 27, 32, 33].
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Deletion of the Cxxc1 gene causes hematopoietic failure and
death
To determine the effect of Cfp1-deficiency in an adult animal, Cxxc1flox/flox Mx1-
Cre+ (mutant) and Cxxc1flox/flox mice lacking the Mx1-Cre transgene (control)
were induced with poly(I:C) to stimulate expression of the Cre recombinase.
Previous reports demonstrate that induction of the Mx1-Cre transgene causes
efficient deletion of floxed genes in the liver, spleen, and duodenum (70–100%),
deletion to a lesser extent in heart, lung, uterus, thymus, and kidney (40–50%),
even less in muscle and tail (20%), and very little in the brain (less than 10%)
[22]. Also, numerous groups, including ours, demonstrated effective deletion of
floxed genes in the bone marrow following induction of the Mx1-Cre transgene
[27, 32, 33]. As shown in figure 2A, within 4 days after the initiation of Cre
induction, significant deletion of the conditional Cxxc1 gene (DCxxc1) was
detected in bone marrow cells and liver of Cxxc1flox/flox mice carrying the Mx1-Cre
transgene, but not in control animals, and Cfp1 protein was nearly undetectable in
bone marrow cells isolated from mutant mice (Figure 2B). In agreement with
previous data [22], little Cre-mediated Cxxc1 deletion was detected in the brain.
While control animals remained healthy, mutant mice died between 9 and 13 days
after the initiation of poly(I:C) injections (Figure 2C), with more than 80% dying
between 9 and 11 days. Mice carrying the Mx1-Cre transgene but otherwise wild
type, as well as heterozygous Cxxc1flox/wt Mx1-Cre mice, all remained healthy
following induction with poly(I:C).
Necropsies were performed to identify which organ(s) fail coincident with loss
of survival. At 5 and 8 days following Cre induction a loss of cellularity was
apparent in the bone marrow and in the red pulp of the spleen of mutants, with
occasional apoptotic cells observed. The white pulp of the spleen appeared the
same in mutants and controls. In the small intestine, occasional apoptotic cells
were observed in the crypts of mutants, but villus height was unaffected. Loss of
bone marrow cellularity was more severe at 8 days. In the spleen, extensive
accumulation of hemosiderin, likely indicating uptake and degradation of red
blood cell precursors, was observed. By 11 days the loss of cellularity in the bone
marrow and red pulp of the spleen in mutants was much more severe (Figure 2D).
Figure 1. Generation of mice carrying conditional Cxxc1 alleles. (A) Schematic illustrating structures of the endogenous murine Cxxc1 allele, targeting
vector, targeted Cxxc1 allele (Cxxc1-T), conditional Cxxc1 allele (Cxxc1-flox), and disrupted Cxxc1 allele (DCxxc1). (B) Schematic illustrating the PCR
primers used to detect the presence of loxP elements within Cxxc1 alleles. (C) Southern blot analysis performed with EcoRI digested genomic DNA and a
probe for a region of the Cxxc1 locus downstream of the targeting construct detects a 7 kb fragment from the targeted allele (Cxxc1-T) and a 13 kb fragment
from the wild type allele. The presence of the targeted allele is indicated by asterisks. (D) PCR using primers CXXC1F and LOXP1R demonstrates the
presence of a loxP element within intron 1 of the Cxxc1 allele in a subset of ES clones (lanes 1 and 5). (E) Mice carrying the targeted Cxxc1 allele were bred
with mice carrying the EIIa-Cre transgene. Tail DNA isolated from offspring was analyzed by PCR, using primers LOXP1F and CXXC1R, to detect Cre-
mediated recombination events that removed the Neo cassette from intron 1 of the targeted Cxxc1 allele, to produce the conditional Cxxc1-flox allele
(indicated by the presence of the upper band of the doublet) (lanes 2, 4, and 9). (F) Following germline transmission of the putative conditional Cxxc1-flox
allele, tail DNA of offspring was analyzed by PCR to confirm the presence of loxP elements within introns 1 and 14. Primers LOXP1F and CXXC1R were
used to detect the intron 1 loxP element, and primers LOXP3F and LOXP3R were used to detect the loxP element within intron 14. In both cases the
presence of the loxP element leads to the production of a band slightly larger than that produced from the wild type Cxxc1 allele. In addition, the PCR
fragment containing LoxP1 was purified for DNA sequence analysis to confirm its presence and the absence of the NeoR cassette (data not shown). (G)
PCR analysis, using primers LOXP1F and CXXC1R, was performed to identify mice lacking (+/+), heterozygous (+/flox), or homozygous (flox/flox) for the
conditional Cxxc1 allele.
doi:10.1371/journal.pone.0113745.g001
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Figure 2. Ablation of the Cxxc1 gene in adult mice causes death. Mice homozygous for the conditional Cxxc1 allele and carrying or lacking the Mx1-Cre
transgene were injected with poly(I:C) at days 0, 2, and 4. (A) Indicated tissues were collected at day 4 or day 7 following the initiation of Cre induction.
Genomic DNA was isolated and PCR analysis was performed to assess the relative abundance of the conditional Cxxc1 allele (Cxxc1-flox) and recombined
Cxxc1 (DCxxc1) allele, as well as the presence of the Mx1-Cre transgene (Cre). (B) Bone marrow cells were collected 48 hours after a single poly(I:C)
injection and cultured ex vivo for 2 days. Cellular extracts were analyzed for Cfp1 protein levels by western analysis. Actin levels were determined as a
loading control. (C) Animals were observed for survival following initiation of Cre induction. (N512 for each genotype) (D) Light microscopy of femur, spleen,
and liver collected 11 days after initiation of Cre induction. There is a marked depletion of hematopoietic cells in the bone marrow and reduction of red pulp in
the spleen of mutant mice. The liver appears normal.
doi:10.1371/journal.pone.0113745.g002
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No pathology was observed in other tissues, including liver, which exhibits an
efficiency of Cre-mediated Cxxc1 gene ablation similar to that found in bone
marrow (Figure 2A, D).
Given the striking loss of cellularity in hematopoietic organs following ablation
of the Cxxc1 gene, we examined the frequency of mature hematopoietic cells in
the peripheral blood, which were found to decline sharply following Cxxc1 gene
deletion (Figure 3). Neutrophil counts were reduced as early as 5 days after the
initiation of Cre induction and reached a minimum by 8 days. Cell counts for
monocytes and lymphocytes declined initially following poly(I:C) injection in
both mutant and control animals due to the interferon response, as previously
observed [34, 35], but while control counts rebounded, mutant counts remained
low. The lymphoid counts were normalized to day 0 due to differences in the
steady state levels of lymphoid counts in uninduced mutant and control animals.
This difference is likely due to a low level of leakiness from the Mx1-Cre transgene,
as was previously reported [36]. Hematocrits in mutants declined from 40–50% to
less than 10% by day 11. Platelet counts for mutants and controls declined initially
at day 5, but mutant counts continued to decline to only 100 K/ml by day 11, while
control counts recovered. In summary, these findings indicate that deletion of the
Cxxc1 gene results in hematopoietic failure and death.
Deletion of the Cxxc1 gene in the bone marrow is sufficient to
cause apoptosis, hematopoietic failure, and death
Additional studies were performed to assess whether the observed failure of
hematopoiesis and subsequent death following Cxxc1 deletion reflects a Cfp1
function intrinsic to cells in the bone marrow. Bone marrow cells were isolated
from mutant or control mice and transplanted separately into lethally-irradiated
wild type recipients. The donor cells were allowed to engraft for 2–3 months, and
then Cre-mediated deletion of the Cxxc1 gene was induced with poly(I:C).
Unexpectedly, the neutrophil, monocyte, and lymphocyte counts for recipients of
both mutant and control cells were initially elevated compared to non-
transplanted mutant and control mice (Figures 3 and 4). Importantly, however,
blood counts for all recipients of mutant bone marrow declined to similar levels
and with similar kinetics to those of induced Cxxc1flox/flox Mx1-Cre mutant mice
(Figure 4). Further, these recipients all died 9 days after induction, also similar to
the mutant mice (Figure 2C). The recipients of control bone marrow remained
healthy, with blood counts comparable to those of Cxxc1flox/flox mice lacking the
Mx1-Cre transgene.
Upon Cxxc1 gene deletion, the loss of bone marrow cellularity in mice
transplanted with mutant bone marrow resembled that observed in
Cxxc1flox/floxMx1-Cre mice (Figure 5A). The bone marrow cellularity of mice
transplanted with mutant cells was 48% of controls (7.26106 cells per femur
compared with 156106) at 9 days after induction of Cxxc1 gene deletion.
Similarly, at 8 days after initiation of deletion, bone marrow cellularity in mutant
Cxxc1flox/floxMx1-Cre mice was 9.66106 cells per femur, a decline to 62% of
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Figure 3. Peripheral blood cells are depleted following ablation of the Cxxc1 gene.Mice homozygous for
the conditional Cxxc1 allele and carrying or lacking the Mx1-Cre transgene were injected with poly(I:C) at
days 0, 2, and 4. Peripheral blood cell counts were determined at days 0, 5, 8 and 11 following the initiation of
Cre induction for (A) neutrophils, (B) monocytes, (C and D) lymphocytes, (E) red blood cells (hematocrit), and
(F) platelets. Open triangles, Cxxc1f/f Cre2 control mice; filled triangles, Cxxc1f/f Cre+ mice. Asterisks denote a
statistically significant reduction in cell numbers following ablation of the Cxxc1 gene (P,0.02). N53–7 for
each of two independent experiments.
doi:10.1371/journal.pone.0113745.g003
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Figure 4. Hematopoiesis failure following Cxxc1 gene ablation is intrinsic to bone marrow cells. Bone
marrow was harvested from mice homozygous for the conditional Cxxc1 allele and either carrying or lacking
the Mx1-Cre transgene and used to transplant lethally-irradiated wild type recipient mice. Following a several
month period for engraftment, transplanted mice were injected with poly(I:C) at days 0, 2, and 4, and
peripheral blood cell counts were determined at the indicated days following initiation of Cre induction as
described for Figure 3. Open triangles, Cxxc1f/f Cre2 control mice; filled triangles, Cxxc1f/f Cre+ mice.
Asterisks denote a statistically significant reduction in cell numbers following ablation of the Cxxc1 gene
(p#0.02). N55 for recipients of mutant bone marrow and N56 for recipients of control bone marrow for each
of two independent experiments.
doi:10.1371/journal.pone.0113745.g004
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controls (15.46106 cells per femur). Overall, these findings indicate that the death
of Cxxc1flox/flox Mx1-Cre mice after Cxxc1 gene deletion resulted from a bone
marrow cell-intrinsic Cfp1 deficiency and the ensuing hematopoietic failure.
Figure 5. Bone marrow exhibits decreased cellularity and increased apoptosis, but no change in global cytosine methylation, following ablation
of the Cxxc1 gene. (A) Following transplantation of control or mutant bone marrow (N52 and N53 recipients, respectively), poly(I:C) was injected on days
0, 2, and 4, and on day 9 following initiation of Cre induction total bone marrow cells were isolated and analyzed (P50.04). Similarly, control or mutant mice
were induced with poly(I:C), and on day 8 following initiation of Cre induction, total bone marrow was analyzed; N511 controls and N516 mutant mice
(P,0.0001). (B) Bone marrow cells were collected from mice of the indicated genotypes on day 8 after day 0, 2, and 4 poly(I:C) injections, and cells were
analyzed for apoptosis by flow cytometry using Annexin V and PI staining (‘‘in vivo BM’’); N56 for Cre- and N55 for Cre+ for each of two independent
experiments. Alternatively, after a poly(I:C) injection on day 0, bone marrow was collected on day 2 from mice of the indicated genotypes, cultured ex vivo,
and then analyzed for apoptosis by Annexin V and PI staining at days 3, 4, and 5 following initiation of Cre induction (‘‘in vitro cultured BM’’); for each
genotype, N54 for day 3 and N57 for days 4 and 5 (P#0.0003) for each of two independent experiments. Asterisks denote statistically significant
differences in cell number or frequency in total LDBMCs. (C) Genomic DNA was isolated from ex vivo cultured bone marrow cells as described in (B). Global
genomic cytosine methylation levels were determined using a methyl-acceptance assay, as previously described [9]. Similar analysis was done using DNA
isolated from wild type or Cfp1-null ES cells as controls. Asterisk denotes a statistically significant difference (P,0.001).
doi:10.1371/journal.pone.0113745.g005
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The striking loss of cells in the bone marrow and red pulp of the spleen, and the
coincident observation of infrequent apoptotic cells in these tissues, suggests that
Cfp1-deficiency might cause apoptosis. Therefore, Cxxc1 deletion was induced in
mutant mice, and the presence in the bone marrow of Annexin-V positive, 7-AAD
negative staining cells undergoing apoptosis was detected 8 days after Cre
induction and compared with that for identically treated controls. As shown in
Figure 5B, the frequency of apoptotic cells increased 66% (P50.0015) in the bone
marrow of mutants compared to controls, indicating that increased programmed
cell death likely contributes to the loss of bone marrow cells after Cxxc1 deletion.
Since apoptotic cells in the bone marrow are rapidly subjected to phagocytosis
by macrophages [37], the data derived from analysis of bone marrow cells is likely
an underestimate of the level of apoptosis that occurs following Cxxc1 gene
deletion. As an alternative approach, Cxxc1 deletion was induced in vivo, and
then the frequency of bone marrow cells undergoing apoptosis was detected at
various times following ex vivo culturing (Figure 5B). Approximately 4-fold more
apoptotic cells were detected in cultures of induced mutant cells than for control
cells 4 and 5 days after induction (P50.0003 and P,0.0001, respectively).
Surprisingly, and in contrast to the situation in Cxxc1-null ES cells [9], methyl-
acceptance assays failed to detect reduced levels of global genomic 5-
methylcytosine in Cfp1-deficient total bone marrow cells that lack Cfp1 and
exhibit elevated rates of apoptosis (Figure 5C). Overall, these findings further
indicate the requirement of Cfp1 for bone marrow cell survival.
Cxxc1 gene deletion causes loss of lineage-restricted
hematopoietic progenitors but not populations enriched for
hematopoietic stem and primitive progenitor cells
Additional studies were conducted to investigate at what stage(s) of ontogeny
hematopoietic cells are lost following Cxxc1 gene deletion. Assays were performed
to quantify hematopoietic progenitors following Cxxc1 gene deletion. Progenitor
methylcellulose colony assays revealed that few functional myeloid progenitors
remained by 8 days post-Cre induction (Figure 6A). Bone marrow progenitors
exhibited an 18-fold decline following Cre induction, and spleen progenitors
declined 85-fold (Figure 6A, P50.016 and P,0.0001, respectively). Consistent
with the loss of all lineages of mature cells in the peripheral blood (Figure 3),
progenitors for all lineages assayed (erythroid, granulocyte, macrophage) were
dramatically reduced, as well as more primitive colony-forming unit-mixed
lineage (granulocyte-erythrocyte-macrophage-megakaryocyte) progenitors (CFU-
GEMM).
For this functional assay, progenitors must differentiate and form a colony of
mature hematopoietic cells to be counted. Progenitor cells that might have been
present but unable to proliferate and differentiate would not have been detected.
Our previous studies established that Cfp1-deficient ES cells are unable to
differentiate in vitro [9], so if Cfp1-deficiency also impairs the ability of
hematopoietic progenitors to differentiate, the methylcellulose colony assay would
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fail to detect these progenitors. Therefore, immunophenotypic analysis was used
to identify populations of cells enriched for various types of hematopoietic
progenitors. Cxxc1 gene deletion was induced in Cxxc1flox/floxMx1-Cre mice and
Figure 6. Hematopoietic progenitor cell populations are sensitive to Cfp1 depletion. Mutant and control mice were induced with poly(I:C) injections at
days 0, 2, and 4. Tissues were collected on day 8 following initiation of Cre induction for all analyses. (A) Bone marrow and spleen cells were each collected
and analyzed by colony forming assay for myeloid hematopoietic progenitors. For both tissues, N53 for Cre- controls and N58 for Cre+ mutants. (B–D)
Bone marrow cells were collected, stained for the indicated cell surface markers, and analyzed by flow cytometry. (B) Scatter plot showing a representative
experiment. (C) Summary for frequency per total LDBMCs (percent) of CMP (Lin- Sca1- Kit+ IL7Ra- FcgRII/III lo CD34+), GMP (Lin- Sca1- Kit+ IL7Ra-
FcgRII/III hi CD34+), MEP (Lin- Sca1- Kit+ IL7Ra- FcgRII/III lo CD34-), and CLP (Lin- Sca1 lo Kit lo IL7Ra+). (D) Summary for number of stained cells per
femur. (For C–D, N511 for Cre- controls and N516 for Cre+mutants for three independent experiments.) Asterisks denote statistically significant differences
in cell number or frequency (P#0.03).
doi:10.1371/journal.pone.0113745.g006
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controls, and 8 days later LDBMCs were isolated and the frequency and
abundance of common myeloid progenitors (CMP), granulocyte-macrophage
progenitors (GMP), megakaryocyte-erythroid progenitors (MEP), and common
lymphoid progenitors (CLP) were determined by detecting the relevant
immunophenotypic markers (Figure 6B–D). The frequency per total LDBMCs of
each of these progenitor populations was significantly reduced following Cxxc1
gene ablation. CMP frequency declined 3.4-fold, GMP declined 6.4-fold, and MEP
fell 2.8-fold (P,0.0001). CLP frequency declined slightly but not by a significant
amount. However, because of reduced overall bone marrow cellularity, these
reductions appear greater when expressed as number of progenitor cells per femur
(Figure 6D), and a significant 2.0-fold reduction in CLP number became apparent
(P50.03). Myeloid progenitor numbers declined 4.9- to 10.2-fold (P,0.0001).
These findings indicate that the reduction in myeloid progenitors detected in
colony forming assays results from a loss of progenitors and possibly their
inability to differentiate as well. Taken together, these data indicate that Cfp1-
deficiency results in the loss of both myeloid and lymphoid progenitors.
To investigate the requirement for Cfp1 in more primitive hematopoietic cells,
the frequency of a phenotypically defined population of Lin- Sca+ c-Kit+ (LSK)
cells, enriched for HSCs and MPPs [38, 39] was determined by flow cytometric
analysis of mutant or control LDBMCs isolated 8 days after induction of Cre
recombinase. The frequency and number per femur of LSK cells in mutant
animals was 3.4-fold and 2-fold greater than controls, respectively (Figure 7A–C,
P,0.0001), in striking contrast with the marked loss of progenitors and mature
cells at this time point. Analysis of further-refined bone marrow cell populations
revealed that cells enriched with long term HSCs (LSK, CD34- Flt3-) or short term
HSCs (LSK, CD34+ Flt3+) both exhibit increases in cell frequency following Cxxc1
gene ablation (2.3- and 1.9-fold increases, respectively, with P,0.0001, Figure 7B)
[40]. However, when the number of cells per femur for each population was
considered, increases following Cxxc1 deletion were smaller. The 1.4-fold increase
for LSK, CD34-Flt3- cell number was statistically significant (P50.02), but that
for the LSK, CD34+Flt3+ population was not (Figure 7C). These findings are
consistent with the loss of predominantly more mature bone marrow cells
following Cxxc1 ablation and the preservation of more primitive cells.
Remarkably, the frequency and number of an intermediate cell population (LSK,
CD34+ Flt3-), which is thought to represent a more primitive form of short term
HSCs [41], was dramatically elevated following ablation of the Cxxc1 gene (6.4-
fold and 4.0-fold, respectively; P,0.0001), and the increase of this population
accounts for the majority of the overall increase of mutant LSK cells (Figure 7B–
C). Further, we detected Cxxc1 expression in LSK cells, and this transcript is lost
upon Cxxc1 deletion (Figure 7D), Thus, the tolerance of these cells to Cfp1 loss is
not due to Cxxc1 normally being absent in these cells or to the failure of the Cre
recombinase to induce Cxxc1 deletion in these cell populations.
An increase in proliferation and/or a decrease in apoptosis of Cfp1-deficient
LSK cells might contribute to their increase in number. To measure proliferation
of these cells in vivo, Cxxc1 deletion was induced in Cxxc1flox/floxMx1-Cre mice,
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Figure 7. Hematopoietic cells enriched for stem cells are tolerant of Cfp1 depletion. Mutant and control mice were induced with poly(I:C) injections at
days 0, 2, and 4. Bone marrow cells were collected at day 8 following initiation of Cre induction and analyzed by flow cytometry for the indicated cell surface
markers. (A) Scatter plot showing a representative experiment. (B–C) Summary for enumeration of LSK (Lin- Sca1+ Kit+), LT-HSC (Lin- Sca1+ Kit+ CD34-
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and then BrdU incorporation into DNA was quantified and compared to
identically treated control animals. Poly(I:C) was administered to mutant and
control animals on days 0, 2, and 4 and then 2 mg of BrdU was administered on
day 7 by peritoneal injection. Twenty-four hours later on day 8, bone marrow was
isolated and analyzed for the frequency of BrdU incorporation into LSK cells and
subpopulations. BrdU incorporation in LSK cells from mutant animals was not
increased compared to controls. Instead there was a modest, but significant
decrease in proliferation, with 36% of the mutant LSK cells incorporating BrdU
compared with 51% of the control cells (Figure 7E, p50.0004). Similar but
smaller trends were observed for CD34/Flt3 subpopulations of LSK cells, but the
differences between mutant and control animals were not significant. LSK cells
from mutant and control mice were also examined for apoptosis 8 days after
poly(I:C) injections were initiated. With 6.3% of LSK cells Annexin V+, 7-AAD2
for mutant mice compared with 5.6% for controls, there was no significant
difference for LSK cells undergoing apoptosis (Figure 7F). Together, these results
indicate that neither an increase in proliferation nor a decrease in apoptosis
contribute to the increase in number and frequency of LSK cells that follows
Cxxc1 deletion. Thus, while mature hematopoietic cells and lineage-committed
progenitors are lost in animals following Cxxc1 gene ablation, the population of
HSCs and primitive progenitor cells expands and is tolerant of Cfp1 depletion.
The accumulation of cells enriched for hematopoietic stem and
primitive progenitor cells following Cxxc1 deletion is distinct from
transient interferon effects
Because poly(I:C) affects hematopoiesis [34, 35], it was important to compare any
effects on hematopoiesis resulting from poly(I:C)-induced Cxxc1 deletion to
poly(I:C) treated controls. This was the case for all of the experiments described in
this report. In addition, LSK frequency was assessed in a time course to gauge the
extent of an interferon effect on LSK frequency at the time when the effects of
Cxxc1 deletion were measured (day 8). On days 0, 2, and 4, poly(I:C) was
administered to mutant and control mice. On days 4, 6, and 8 bone marrow was
isolated and LSK frequency was determined. The presence of CD150, which
further enriches for HSCs, was also determined [42]. As shown in Figure 8, there
was a transient increase in LSK CD150+ frequency in control animals that peaked
at day 4 and returned to the initial level by day 8. In contrast, LSK CD150+
Flt3-), ST-HSC (Lin- Sca1+ Kit+ CD34+ Flt3+), and more primitive ST-HSC (Lin- Sca1+ Kit+ CD34+ Flt3-). (A) and (B) present the data in terms of percent of
total LDBMCs, while (C) presents cell number per femur. (For B–C, N511 for Cre- controls and N516 for Cre+ mutants for each of three independent
experiments.) (D) Total RNA was isolated from purified LSK cells derived from the bone marrow of mice of the indicated genotypes (day 8 after poly(I:C)
injections on days 0, 2, and 4), and semi-quantitative RT-PCR was performed to determine the level of Cxxc1 transcript. RNA from wild type or Cxxc1-null
ES cells was used as positive and negative controls, respectively [9]. The conditions for all PCR reactions were confirmed to be within the linear range (data
not shown). (E) Mutant and control mice were induced with poly(I:C) injections on days 0, 2, and 4, and BrdU was injected on day 7. On day 8 following
initiation of Cre induction, bone marrow was isolated and analyzed for the frequency of BrdU incorporation into LSK cells and CD34/Flt3 subpopulations.
Asterisks denote statistically significant differences (P#0.02). (F) LSK cells were recovered from the bone marrow of mutant or control mice 8 days following
Cre induction and examined for apoptosis by Annexin V and PI staining.
doi:10.1371/journal.pone.0113745.g007
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frequency in Cxxc1 mutants increased more than 14-fold by day 6 and remained
elevated at day 8. At days 4, 6, and 8, LSK CD150+ frequency following Cfp1
depletion was 1.7-, 3.2-, and 9.7-fold greater than that of the control. Therefore,
there was a transient increase in LSK CD150+ cells caused by poly(I:C) itself, but a
much greater and sustained increase in these cells resulted from Cxxc1 deletion.
Discussion
Cfp1 is a ubiquitously expressed regulator of both cytosine and histone
methylation, and Cfp1-deficient mouse embryos fail to develop past gastrulation.
Cfp1-null ES are viable but unable to differentiate in vitro, suggesting an essential
role for Cfp1 in regulating chromatin states during development. Mice carrying a
conditional deletion allele of the Cxxc1 gene were developed to analyze Cfp1
function in adult animals. The studies reported here demonstrate that acute
depletion of the epigenetic regulator Cfp1 in an adult animal leads to death within
two weeks as a consequence of hematopoiesis failure, demonstrating that Cfp1 is
required for the survival of differentiating hematopoietic cells. A recent survey of
425 chromatin-associated factors documented that multiple components of the
zebrafish Set1 complex, including Cfp1, are required for definitive hematopoiesis
[43]. Together with previous findings from our laboratory that Cfp1 is required
for primitive hematopoiesis during zebrafish embryogenesis [19] and for the
survival of a human leukemia cell line [20], these results demonstrate that Cfp1 is
required for the survival of differentiating hematopoietic cells.
The ability to ablate the Cxxc1 gene in an adult animal offers an opportunity for
detailed study of the sensitivity of cells to Cfp1 depletion at various stages of
ontogeny. Remarkably, despite a nearly complete loss of lineage-committed
progenitors and mature hematopoietic cells, bone marrow LSK cells enriched for
HSCs and MPPs persist and expand after Cxxc1 deletion. Many other investigators
Figure 8. The accumulation of LSK CD150+ cells following Cxxc1 deletion is distinct from transient
interferon effects. Mutant and control mice were induced with poly(I:C) injections on days 0, 2, and 4, and
bone marrow was analyzed by flow cytometry for LSK-CD150+ frequency on days 4, 6, or 8 following initiation
of Cre induction. N54 or 5 for each genotype and each time point. Asterisks denote statistically significant
differences (P#0.01).
doi:10.1371/journal.pone.0113745.g008
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have utilized the Mx1-Cre transgene system to mediate target gene ablation in
HSCs and MPPs [44, 45, 46, 47, 48, 49], and our data confirm Cre-mediated
depletion of the Cxxc1 transcript in LSK bone marrow cells. Thus, these data
reveal that while Cfp1 is required in hematopoietic progenitors undergoing
differentiation and lineage-commitment, HSCs and MPPs are tolerant of its
depletion. The finding of an expanded LSK compartment in the bone marrow
following Cfp1 depletion, coincident with the nearly complete loss of progenitor
cells and mature peripheral blood cells, is unusual and highlights the distinct
epigenetic requirements for HSC/MPP maintenance and differentiation programs.
The observed expansion of LSK cells upon loss of Cfp1 is associated with
decreased cell proliferation and no significant change in the rate of apoptosis,
suggesting that these cells exhibit a defect in differentiation. The accumulation of
a primitive form of short term HSCs (CD34+ Flt3-) in the bone marrow following
Cfp1 depletion suggests a differentiation block at an early stage of hematopoietic
development. This is consistent with previous work that showed differentiation
defects in Cfp1-null ES cells as well as Cfp1-null blastocysts [9, 12]. We also
demonstrated previously that ES cells lacking Cfp1 exhibit decreased levels of
cytosine methylation and increased levels of histone H3-Lys4 methylation,
indicating reduced levels of heterochromatin in these cells [9, 13, 14]. Because
heterochromatin formation is necessary for lineage commitment and restriction
of developmental potential of stem cells [5, 6], taken together, these findings
suggest that Cfp1 is required to facilitate remodeling of chromatin structure that is
associated with stem cell differentiation. We cannot exclude the possibility that
expansion of LSK cells following loss of Cfp1 reflects inappropriate induction of
stem cell markers in non-stem cells as a consequence of perturbed epigenetic
regulation of gene expression.
Modulation of a number of chromatin regulators has been shown to expand
HSC number and/or activity. For example, loss of appropriate chromatin
structure is implicated in the phenomenon of HSC exhaustion following
replicative stress. But this can be prevented by over-expression of the Polycomb
group protein Ezh2, a regulator of histone methylation and deacetylation [50].
Furthermore, treatment of HSCs with inhibitors of DNA methyltransferases
(azacytidine) and histone deacetylases (trichostatin A, valproic acid) leads to
altered cell fate and an expansion ex vivo of HSCs that retain bone marrow-
repopulating potential [51, 52, 53, 54, 55].
Cfp1 physically interacts with Dnmt1 [10] and facilitates maintenance cytosine
methylation, and a decline in global genomic cytosine methylation is the most
obvious molecular defect observed in ES cells depleted of Cfp1 [9, 19]. However,
apoptosis of hematopoietic cells following Cfp1 depletion occurs without a change
in global cytosine methylation levels. Furthermore, ablation of a conditional
Dnmt1 gene leads to hematopoietic failure associated with a rapid loss of LSK cells
[56], in sharp contrast with the expansion of LSK cells that occurs following
ablation of the Cxxc1 gene. Thus, the hematopoietic failure observed upon Cfp1
depletion does not appear to be a consequence of altered Dnmt1 function.
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Interestingly, similar to the Cfp-1 null phenotype, Mx1-Cre driven ablation of
the murine de novo DNA methyltransferase Dnmt3a gene leads to an expansion of
the HSC compartment and coincident decline in differentiation potential
following serial bone marrow transplantations [57]. Also similar to ex vivo Cfp1-
null bone marrow cells, Dnmt3a-null HSCs don’t exhibit altered global levels of
genomic cytosine methylation, although gene-specific hyper- and hypomethyla-
tion were detected, including hypomethylation and incomplete repression of
HSC-specific genes. It should be noted that global de novo DNA methyltrans-
ferase activity is normal in Cfp1-null ES cells, although the relative contributions
of the Dnmt3a and Dnmt3b de novo methyltransferases were not distinguished
[9]. The similarity of the knock-out phenotypes may suggest a previously
unrecognized functional interaction between Cfp1 and Dnmt3a. Thus, further
gene-specific interrogation of cytosine methylation patterns in Cfp1-null HSCs
might be informative.
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